|

Gene therapy from China

Scenic view of the Great Wall of China surrounded by autumn foliage and foggy mountains.

Cell and Gene therapy from China is cheap because all the COGS are lower. COGS, research and studies are planned for affordability right at the beginning. However, cheap does not mean that the quality is bad. However, the cost is not very very low because the companies need to move to profitability too. In China the total cost $50k /year is the total that is reimbursable for treatment. Another advantage is that they are setting up everything new so it is also an advantage of second mover with specific purpose built tools, processes, and plans. Chinese companies do want to be global and so are planning development that is fast, their results are published and they are seeking collaborations. The ecosystem also makes it available for internal companies but also global companies.

Some leaders in the field that have expressed their opinion on Endpoints day

Xiao Xioa – Belief Biomed Inc

Emma Wang – CDO/CTA YolTech Therapeutics

Zhenhua Wu – Exegenesis Bio

Lijun Wang – Cojourney

Similar Posts

  • |

    Bisphenol A

    There is lot of information on BPA on wikipedia that talks about its use in plastics especially polycarbonates that are used in water bottle manufacturing. Polycarbonate bottles are transparent and can contain 90% BPA by mass It is not a plasticizer. The concern for its use comes from its effect as a weak xenoestrogen disrupting…

  • Synthetic biology dyes

    A synthetic biology company called Huue is going forward to create dye’s from bacteria. The cool part is that they are taking machinery that is in plants and introducing them into bacteria.An advantage is that you could manipulate and then come up with new dyes. The dye Huue has started with is called Indigo and…

  • |

    AI for drug discovery

    There are many companies that promise AI for drug discovery such as ChatGPT from OpenAI, Anthropic’s AI suite and Perplexity and there are more companies coming up too. One specific company that is unusual is that it seems to be promising much more deeper understanding of the drug discovery pathways then the others. It can…

  • Flu vaccine – FAST

    Translational Medicine had a paper by Dr Dormitzer from Novartis and Dr Venter of creating a flu vaccine in just about 4 days and 4 hours, as opposed to months and weeks that it used to take previously. They used the sequence supplied by Biomedical Advanced Research and Development Authority and transfecting it into tissue culture…

  • | |

    Technology – implementation

    Consider In-vitro fertilization (IVF). The research for that had begun in early 1900’s till the first successful IVF transplantation and successful birth in 1978. It took several years for the technology to get adopted till nearly 50 years later when about 1-2% of all births are now IVF enabled. One of the issues that bogged…